Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2008 Oct;14(10):1020-1.
doi: 10.1038/nm1008-1020.

Portal to Alzheimer's disease

Comment

Portal to Alzheimer's disease

Anatoly A Starkov et al. Nat Med. 2008 Oct.

Abstract

Genetic inactivation of the mitochondrial self-destruction mechanism improves cognition in a mouse model of Alzheimer’s disease (pages 1097–1105).

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mitochondria in Alzheimer’s disease. In nondiseased neurons, the mPTP is closed, and mitochondria produce ATP and maintain other functions. Cytosolic calcium levels are kept low via ATP-dependent sequestration into endoplasmic reticulum (ER), ATP-dependent extrusion through the Ca2+-ATPase of the plasma membrane (not shown) and energy-dependent sequestration into mitochondria. However, in neurons affected with Alzheimer’s disease, an accumulation of soluble Aβ results in elevated cytosolic calcium levels owing to leaks from Aβ-modified calcium-conducting channels in the ER and plasma membrane. Elevated cytosolic calcium may result in calcium overload of mitochondria. An accumulation of Aβ in mitochondria and its direct interaction with CypD promotes calcium-induced mPTP opening, which damages mitochondrial ultrastructure, inhibits mitochondrial ATP production and other energy-dependent functions, and releases calcium stored in mitochondria, thereby further deregulating neuronal calcium signaling. Finally, an energy deficit and a release of proapoptotic proteins from damaged mitochondria results in neuronal injury.

Comment on

References

    1. Hardy J, Allsop D. Trends Pharmacol Sci. 1991;12:383–388. - PubMed
    1. Cerpa W, Dinamarca MC, Inestrosa NC. Curr Alzheimer Res. 2008;5:233–243. - PubMed
    1. Reddy PH, Beal MF. Trends Mol Med. 2008;14:45–53. - PMC - PubMed
    1. Green KN, LaFerla FM. Neuron. 2008;59:190–194. - PubMed
    1. Sanz-Blasco S, Valero RA, Rodriguez-Crespo I, Villalobos C, Nunez L. PLoS ONE. 2008;3:e2718. - PMC - PubMed

MeSH terms